Compare CMG & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | MDLN |
|---|---|---|
| Founded | 1993 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2B | 37.4B |
| IPO Year | 2005 | N/A |
| Metric | CMG | MDLN |
|---|---|---|
| Price | $32.90 | $41.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 23 |
| Target Price | $46.85 | ★ $50.48 |
| AVG Volume (30 Days) | ★ 14.0M | 4.6M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.70 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $11,925,601,000.00 | N/A |
| Revenue This Year | $9.66 | $10.88 |
| Revenue Next Year | $11.03 | $7.69 |
| P/E Ratio | ★ $140.33 | $658.75 |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $29.77 | $38.50 |
| 52 Week High | $58.42 | $50.88 |
| Indicator | CMG | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 36.42 |
| Support Level | $30.18 | $38.50 |
| Resistance Level | $35.14 | $44.11 |
| Average True Range (ATR) | 1.08 | 1.67 |
| MACD | -0.20 | -0.45 |
| Stochastic Oscillator | 22.22 | 15.74 |
Chipotle is a leading fast-casual, Mexican-inspired restaurant chain, generating $11.9 billion in sales across 3,983 company-operated US locations, 104 international units primarily in Canada and Europe, and 14 licensed stores largely operated in the Middle East at the end of 2025. The firm's revenue is primarily driven by food and beverage sales at its company-owned restaurants, supplemented by delivery fees generated through its first-party digital channels. Chipotle emphasizes ingredients with no artificial flavors and utilizes an efficient, assembly line service model to serve mainly customizable burritos, bowls, salads, quesadillas, and tacos.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.